EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring CDKN1A Upregulation Mechanisms: Insights into Cell Cycle Arrest Induced by NC2603 Curcumin Analog in MCF-7 Breast Cancer Cells

Felipe Garcia Nishimura iD, Beatriz Borsani Sampaio iD, Tatiana Takahasi Komoto iD, Wanessa Julia da Silva iD, Mariana Mezencio Gregório da Costa, Gabriela Inforçatti Haddad, Kamila Chagas Peronni iD, Adriane Feijó Evangelista iD, Mohammad Hossain iD, Jonathan R Dimmock, Brian Bandy iD, Rene Oliveira Beleboni iD und 2 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25094989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Felipe Garcia Nishimura und 13 weiteren Autor:innen. Beteiligte Einrichtung: Unidade de Biotecnologia, Universidade de Ribeirão Preto (UNAERP), Ribeirao Preto 14096-900, Brazil. Hauptthemen laut MEDLINE: Curcumin, Breast Neoplasms, Cyclin-Dependent Kinase Inhibitor p21, Cell Cycle Checkpoints. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer stands out as one of the most prevalent malignancies worldwide, necessitating a nuanced understanding of its molecular underpinnings for effective treatment. Hormone receptors in breast cancer cells substantially influence treatment strategies, dictating therapeutic approaches in clinical settings, serving as a guide for drug development, and aiming to enhance treatment specificity and efficacy. Natural compounds, such as curcumin, offer a diverse array of chemical structures with promising therapeutic potential. Despite curcumin’s benefits, challenges like poor solubility and rapid metabolism have spurred the exploration of analogs. Here, we evaluated the efficacy of the curcumin analog NC2603 to induce cell cycle arrest in MCF-7 breast cancer cells and explored its molecular mechanisms. Our findings reveal potent inhibition of cell viability (IC50 = 5.6 μM) and greater specificity than doxorubicin toward MCF-7 vs. non-cancer HaCaT cells. Transcriptome analysis identified 12,055 modulated genes, most notably upregulation of GADD45A and downregulation of ESR1, implicating CDKN1A-mediated regulation of proliferation and cell cycle genes. We hypothesize that the curcumin analog by inducing GADD45A expression and repressing ESR1, triggers the expression of CDKN1A, which in turn downregulates the expression of many important genes of proliferation and the cell cycle. These insights advance our understanding of curcumin analogs’ therapeutic potential, highlighting not just their role in treatment, but also the molecular pathways involved in their activity toward breast cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminBreast NeoplasmsCyclin-Dependent Kinase Inhibitor p21Cell Cycle CheckpointsGene Expression Regulation, NeoplasticHumansMCF-7 CellsFemaleUp-RegulationCell ProliferationCell SurvivalCell Cycle ProteinsEstrogen Receptor alphaAntineoplastic AgentsGADD45 Proteins

Stichwörter der Autor:innen

MCF-7breast cancercancercell cycle arrestcurcumincurcumin analogsp21transcriptomics

Substanzen

CurcuminCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21GADD45A protein, humanCell Cycle ProteinsEstrogen Receptor alphaESR1 protein, humanAntineoplastic AgentsGADD45 Proteins

Autor:innen und Institutionen

  • Unidade de Biotecnologia, Universidade de Ribeirão Preto (UNAERP), Ribeirao Preto 14096-900, Brazil.
  • Instituto para Pesquisa do Cancêr (IPEC), Guarapuava 85051-060, Brazil.
  • Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation, Manguinhos, Rio de Janeiro 21040-900, Brazil.
  • School of Sciences, Indiana University Kokomo, Kokomo, IN 46904, USA.
  • College of Pharmacy and Nutrition, University of Saskatchewan (USask), Saskatoon, SK S7N 5A2, Canada.

ORCID-Profile: Felipe Garcia Nishimura, Beatriz Borsani Sampaio, Tatiana Takahasi Komoto, Wanessa Julia da Silva, Kamila Chagas Peronni, Adriane Feijó Evangelista, Mohammad Hossain, Brian Bandy, Rene Oliveira Beleboni, Ana Lucia Fachin

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Zitieren

APA

Nishimura, F. G., Sampaio, B. B., Komoto, T. T., da Silva, W. J., da Costa, M. M. G., Haddad, G. I., Peronni, K. C., Evangelista, A. F., Hossain, M., Dimmock, J. R., Bandy, B., Beleboni, R. O., Marins, M., & Fachin, A. L. (2024). Exploring CDKN1A Upregulation Mechanisms: Insights into Cell Cycle Arrest Induced by NC2603 Curcumin Analog in MCF-7 Breast Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094989

Vancouver

Nishimura FG, Sampaio BB, Komoto TT, da Silva WJ, da Costa MMG, Haddad GI, et al. Exploring CDKN1A Upregulation Mechanisms: Insights into Cell Cycle Arrest Induced by NC2603 Curcumin Analog in MCF-7 Breast Cancer Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094989

BibTeX
@article{Nishimura2024,
  author = {Nishimura, Felipe Garcia and Sampaio, Beatriz Borsani and Komoto, Tatiana Takahasi and da Silva, Wanessa Julia and da Costa, Mariana Mezencio Gregório and Haddad, Gabriela Inforçatti and Peronni, Kamila Chagas and Evangelista, Adriane Feijó and Hossain, Mohammad and Dimmock, Jonathan R and Bandy, Brian and Beleboni, Rene Oliveira and Marins, Mozart and Fachin, Ana Lucia},
  title = {Exploring CDKN1A Upregulation Mechanisms: Insights into Cell Cycle Arrest Induced by NC2603 Curcumin Analog in MCF-7 Breast Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25094989}
}
Kostenlos starten →